ORION Corp. (KRX:271560)
South Korea · Delayed Price · Currency is KRW 137,400
+1,200 (0.88%)
At close: May 19, 2026
ORION Revenue
In the year 2025, ORION had annual revenue of 3.33T KRW with 7.35% growth. ORION had revenue of 924.58B in the quarter ending December 31, 2025, with 7.28% growth.
Revenue
3.33T
Revenue Growth
+7.35%
P/S Ratio
1.62
Revenue / Employee
2.27B
Employees
n/a
Market Cap
5.38T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.33T | 228.10B | 7.35% |
| Dec 31, 2024 | 3.10T | 191.98B | 6.59% |
| Dec 31, 2023 | 2.91T | 39.11B | 1.36% |
| Dec 31, 2022 | 2.87T | 517.75B | 21.98% |
| Dec 31, 2021 | 2.36T | 125.68B | 5.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| E-MART | 28.97T |
| CJ Cheiljedang | 27.34T |
| BGF Retail | 9.17T |
| KT&G Corporation | 6.58T |
| LG H&H | 6.36T |
| Amorepacific | 4.25T |
| Nongshim | 3.51T |
| Samyang Foods | 2.35T |
ORION News
- 10 months ago - Orion Corporation's financial reporting and Annual General Meeting in 2026 - Benzinga
- 1 year ago - Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe - Business Upturn